BioProtect
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, BioProtect sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,751 sponsors by registered trial count).
BioProtect: 4 sponsored US clinical trials, none currently recruiting.
BioProtect sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. The most-studied condition in this pipeline is Prostate Cancer, with 2 trials.
Upper-quartile sponsor footprint
BioProtect sits in the upper quartile of the sponsor corpus (#2,913 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Prospective Evaluation of a Commercially Available Hydrogel Spacer
NCT05323747
Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)
NCT05423431
BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007
NCT03400150
Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects
NCT00918229
Therapeutic Areas
How the BioProtect archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Prostate Cancer (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.